Blog

Sponsors are uncertain about how to design a DCT to ensure efficient performance delivery, learn how to set your organization up for success.

Using hoods with biological materials depends on directional airflow, and specialized airflow is necessary when handling hazardous materials.

New FDA guidance (ICH q12) applies to pharmaceutical drug substances and products requiring a marketing authorization.

With cannabis usage becoming more popular, there’s an uptick in research surrounding its therapeutic effects.

Advarra experts Sharon Ayd and Leslie Paul answer questions from their webinar, The IND Journey Phase I – Navigating Success.

What happens when an unexpected non-English speaking participant shows up, and there isn’t enough time to obtain a translated study consent?

Global & FDA regulations dictate how researchers organize & store trial documents. Learn the basics of eTMF & eISF clinical research tools

Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed.

June 30, 2022

While the IND application process may be straightforward to some, we explore the most common pitfalls as sponsors prepare for submission.

Four common but critical questions for emerging biotech organizations establishing a pharmacovigilance (PV) organization.

This checklist outlines key milestones and considerations for sites and sponsors in the clinical trial study startup process.